BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 21857575)

  • 1. Bone loss and bone turnover in acute and chronic spinal cord injured patients.
    Paker N; Bugdayci D; Ersoy S; Uysal E; Elbirlik S
    Neurosciences (Riyadh); 2007 Jul; 12(3):232-5. PubMed ID: 21857575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between bone turnover and bone density at the proximal femur in stroke patients.
    Paker N; Bugdayci D; Tekdos D; Dere C; Kaya B
    J Stroke Cerebrovasc Dis; 2009; 18(2):139-43. PubMed ID: 19251190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
    J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
    Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
    J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
    Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
    J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cross-sectional study of bone turnover markers in healthy premenopausal women.
    de Papp AE; Bone HG; Caulfield MP; Kagan R; Buinewicz A; Chen E; Rosenberg E; Reitz RE
    Bone; 2007 May; 40(5):1222-30. PubMed ID: 17331821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased formation of 8-iso-prostaglandin F(2alpha) is associated with altered bone metabolism and lower bone mass in hypercholesterolaemic subjects.
    Mangiafico RA; Malaponte G; Pennisi P; Li Volti G; Trovato G; Mangiafico M; Bevelacqua Y; Mazza F; Fiore CE
    J Intern Med; 2007 Jun; 261(6):587-96. PubMed ID: 17547714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
    Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone.
    Han KO; Choi JT; Choi HA; Moon IG; Yim CH; Park WK; Yoon HK; Han IK
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):349-53. PubMed ID: 15730418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Concentrations of serum bone turnover markers in smoking pregnant women and in umbilical cord blood of newborns].
    Ambroszkiewicz J; Maciejewski T; Chełchowska M; Gajewska J; Laskowska-Klita T
    Przegl Lek; 2009; 66(10):644-7. PubMed ID: 20301901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deteriorated geometric structure and strength of the midfemur in men with complete spinal cord injury.
    Modlesky CM; Slade JM; Bickel CS; Meyer RA; Dudley GA
    Bone; 2005 Feb; 36(2):331-9. PubMed ID: 15780960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of bone loss in paraplegics over 2 years with alendronate.
    Zehnder Y; Risi S; Michel D; Knecht H; Perrelet R; Kraenzlin M; Zäch GA; Lippuner K
    J Bone Miner Res; 2004 Jul; 19(7):1067-74. PubMed ID: 15176988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis.
    Lormeau C; Soudan B; d'Herbomez M; Pigny P; Duquesnoy B; Cortet B
    Bone; 2004 Jun; 34(6):933-9. PubMed ID: 15193539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone loss and mechanical properties of tibia in spinal cord injured men.
    Dionyssiotis Y; Trovas G; Galanos A; Raptou P; Papaioannou N; Papagelopoulos P; Petropoulou K; Lyritis GP
    J Musculoskelet Neuronal Interact; 2007; 7(1):62-8. PubMed ID: 17396008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures.
    Mitra D; Elvins DM; Collins AJ
    J Rheumatol; 1999 Oct; 26(10):2201-4. PubMed ID: 10529140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of bone loss and its mechanisms in anorexia nervosa.
    Legroux-Gérot I; Vignau J; D'Herbomez M; Collier F; Marchandise X; Duquesnoy B; Cortet B
    Calcif Tissue Int; 2007 Sep; 81(3):174-82. PubMed ID: 17668143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone remodeling, bone mass and weight gain in patients with stabilized schizophrenia in real-life conditions treated with long-acting injectable risperidone.
    Doknic M; Maric NP; Britvic D; Pekic S; Damjanovic A; Miljic D; Stojanovic M; Radojicic Z; Jasovic Gasic M; Popovic V
    Neuroendocrinology; 2011; 94(3):246-54. PubMed ID: 21986470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
    Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.